Published in Clinical Oncology Week, March 15th, 2010
"Patients with rare diseases are a medically underserved population in every country," said Francois Nader, M.D., president and chief executive officer of NPS Pharmaceuticals. "At NPS, we have dedicated ourselves to developing drugs that target the underlying cause of rare diseases. We are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.